How's Annette doing??

Discussion in 'GlaxoSmithKline Lab Personnel' started by Anonymous, Oct 14, 2012 at 1:54 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Maybe it's the euphemistic use of the term "investment", you know like when management tells you that you've been deselected, but that your headcount and compensation will be reinvested in some new person who has better skills and lower pay expectations.
    As far as new headcount, seems like the stability lab at Zeb lost 9 staff to EBF, and they were able to hire 2-3 new headcount and 2-3 temps, to attempt backfill.
    No site or department has a lock on surviving the imminent cuts; my advice to everyone is to have your resume ready to send out, and keep making contacts on the Linked-In community.
     

  2. Anonymous

    Anonymous Guest

    Re: "investing" in EBF?

    EBF was simply an accounting shell game. Baldoni moved a bunch of head count off of his books to show he was contributing to budget cuts - same people are doing same work in same place. Just changed dept name from second generation to emerging markets. Same will be happening with process robustitty group. Just moving more headcount from Baldoni's group - this time to GMS's for pseudo savings in head count. same people will be doing same work in same place. Just trying to pretend we're more committed to better quality for GMS by moving headcount to GMS - nothing will change but name of departments and SOPs that will have to be re-written and re-issued and re-read...




    Brilliant! We are trying to improve our dermatology division by re-assigning inhaled product development scientists to that group. Oh yeah, I really see the scientific connection between having expertise in developing an inhaled product and being able to develop a topical product. Another wonderful example of 'enterprise thinking' - just move everyone anywhere there's a need. Hahaha.

    PTS sucks. Always has. Always will. As long Baldoni is around.
     
  3. Anonymous

    Anonymous Guest

    Sorry, but you have your facts wrong, so I'll correct them. The stability group had 23 full time staff in 2010 (analysts). When it was announced that they were moving to Zebulon, they lost 7 staff and 1 manager. Back filled 1 perm. + some contract staff. The back filled perm went back to school and left Zebulon within 1 year. In 2011, the Zebulon stability group lost 6 full time staff to EBF. They lost the 4 head count, but were promised 2 back fill perm hires. Those perm hires were turned into re-invent yourself staff and 2 were moved over to Zebulon in May 2012. Then the stability group lost 1 more staff to the Stiefel/PD collaboration (this month). For those of you who are counting, that's a group of 23 to a group of 9 with 2 re-invent yourself staff and multiple contractors.

    I'm sure that the Zebulon staff are thanking their luck stars that the Zebulon laboratory is so much easier to work in and is significantly more efficient (and friendly, don't forget friendly... and doesn't exude a sense of panic... and has support from the facilities group where there are problems,.... and doesn't have holes in the walls behind the toilets in the rest rooms).

    As was reported at the RTP town hall, no one who works in the stability group likes the Zebulon site and all would move back if offered positions.
     
  4. Anonymous

    Anonymous Guest

    So Annette has named her "new" leadership team. I was surprised that she was not willing to consider candidates from outside the former LT. I mean, if you want to take the division in a new direction, how can you do it with the same players just sitting in different chairs? Of course, if they're all "yes" men/women, they will continue to just tag along. For the two analytical Global Heads, has AK or LFDS ever managed an analytical department prior? I was expecting MW to get one of those. And for API Chemistry, isn't VN all about OE, so we can expect more leaning and outsourcing. Pretty clear that the inhaled portfolio has taken another kick in the crotch, with MJ and RL exiting to the garden. Interesting that there's no one from RTP on the LT; is that a message?
     
  5. Anonymous

    Anonymous Guest

    @ #24 : In the former PD LT there was only Clive M. from RTP so, with him retiring in a few months, there was really no one eligible from RTP to be named to the new LT. There is likely a concern for the process chemists who were moved from the North Building (now a pile of rubble) to Stiefel; Stiefel is scheduled to be vacated so where is the "lost tribe from North" going?
     
  6. Anonymous

    Anonymous Guest

    No one from RTP eligible for the LT? Huh?

    A) you are a moron
    B) RTP is in such bad shape to have no leaders that it should be closed
    C) both A & B are true
     
  7. Anonymous

    Anonymous Guest

    I bet that you miss your daily rides on the short bus, don't you?
    Let me explain it in simple terms so maybe even you will understand - - Annette limited her selection of members of her new LT to the members of her current LT. On the current LT from RTP was one person (Clive M). He announced his retirement, so he wasn't in the running to be named to Annette's new LT. Therefore no one from RTP was eligible.
    If you still don't understand, then you will find the real moron in the mirror.
     
  8. Anonymous

    Anonymous Guest

    Oh wise one, please explain to us on the short bus why Annette limited her selection to current LT?

    We await your wisdom.

    So, setting up an arbitrary selection rule and sticking with it is a satisfying explanation to you?

    You probably also believe in God.
     
  9. Anonymous

    Anonymous Guest

    You're missing the big picture dude.

    Annette created her little rule about not choosing anyone not already on her LT knowing that only one person (Clive) was currently from RTP (after having worked for years in UK) and knowing that Clive was going to retire.

    If you don't think that not having any representation on the LT from a major R&D site doesn't sends a message to the scientists working at that site, well, let's just say we can find a spot for you on the short bus with the rest of us.
     
  10. Anonymous

    Anonymous Guest

    I'm not in PST. But it sounds like you are having a major re-org without getting rid of anyone who was in charge of the old-org.

    Is there anyone on this planet who thinks that's a course that will lead to any improvements?

    Just another deck-chair-on-the-Titanic exercise.
     
  11. Anonymous

    Anonymous Guest

    Re: How's Annette's Re-org doing??

    You have a VP that is restructuring the entire division, but has a 'rule' that no one can report to her in the new organisation that isn't already reporting to her under the old organisation?

    You, my friends, are doomed.

    I wish I could use that 'rule' on my boss:

    You see boss, I can't try any new experimental techniques. Unless I am already using a particular technique, it isn't eligible for me to try it. But I am really sure that I will solve the problem facing us.

    HA!HA!HA!HA!

    I haven't heard anything so childish since grade school days.
     
  12. Anonymous

    Anonymous Guest

    Yes.
     
  13. Anonymous

    Anonymous Guest

    Doing a good job demonstrating that a woman can do just as bad a job at running PD as any man has done.

    Her reorg plans are laughable.

    Rolling back organization to silo approach and retaining the current crop of yes-man and yes-woman as her direct reports.

    If PD is sooooooooo messed-up that it needs a major reorg, WHY THE HECK DO WE KEEP THE SAME LEADERS WHO GOT US HERE?
     
  14. Anonymous

    Anonymous Guest

    Re: reorgs = accounting shell game

    confirmed: latest reorg is just a way of having GMS assume financial responsibility for 2G group
     
  15. Anonymous

    Anonymous Guest

    Hmm. By this reasoning if Annette currently only has white people reporting to her, she doesn't ever have to hire non-whites because non-whites are not eligible. Hmm. Probably explains GSK's current demographics. Thanks for pulling the 'sheet' off of GSK's hiring policies.
     
  16. Anonymous

    Anonymous Guest

    Re: "investing" in EBF?

    Gospel.
     
  17. Anonymous

    Anonymous Guest

    Gospel. Gospel.
     
  18. Anonymous

    Anonymous Guest

    So, is it true that the new PD LT is meeting in the UK this week, presumably to sort out the next level of the organizational pyramid? Let me predict what they will accomplish: draft a mission statement, participate in some kind of "Orange Day" activity, and each of them will reveal a surprising factoid from their personal bio. I hope that one of them reveals that they can play the fiddle, so the analogy will be complete.
     
  19. Anonymous

    Anonymous Guest

    Add circle jerk to the list.
     
  20. Anonymous

    Anonymous Guest

    Well, let's see. No one from RTP was selected to leadership team and now RTP has been down graded to a satellite site picking up the odd ball functions: Derm / EBF / line extensions / catalysts? - ha, ha, ha. Seriously, that's what's left for RTP? Becoming experts in catalysts!

    While UP is now the center of universe (or at least the center of all US activity).

    Looks like 1 + 1 = 2 after all.

    EDS-RTP is simply holding on because they are temporairly tied to a DPU. Once the re-building is done in UP and the remaining DPUs move from RTP to UP, RTP will further erode to meaninglessness.

    Waiting for your positive spin on this one.